Back to Authors

Cooper, James Fenimore

Mayo Clinic

Annexon Biosciences (United States)

Citations 1

Enduring Responses after 1-Year, Fixed-Duration Cevostamab Therapy in Patients with Relapsed/Refractory Multiple Myeloma: Early Experience from a Phase I Study
Trudel, Suzanne , Spencer, Andrew , Forsberg, Peter A. , Laubach, Jacob P. , Mateos, María‐Victoria , Kaedbey, Rayan , Krishnan, Amrita , Choeurng, Voleak, Cooper, James Fenimore, Sumiyoshi, Teiko, Wong, Chihunt, Lesokhin, Alexander M. , Richter, Joshua , Cohen, Adam D. , Thomas, Sheeba K. , Bahlis, Nizar Jacques , Costa, Luciano J. , Rodríguez‐Otero, Paula , Berdeja, Jesús G. , Fonseca, Rafaël , Harrison, Simon J

Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 4415-4417

10.1182/blood-2022-157547 Get It